The Influence of the Volume of Injuries and Surgical Operations on the Results of Pain Treatment in Patients With Gunshot and Mine-explosive Wounds at the Stages of Treatment
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2,215
- 试验地点
- 1
- 主要终点
- The Hospital Anxiety and Depression Scale
研究概览
简要总结
Treatment of pain in patients with gunshot and mine-explosive injuries in the stages of treatment is important, because in 82.1% the pain becomes chronic. This indicates that treatment results need to be improved. One of the factors that can influence the outcome of pain treatment is the extent of damage and surgery.
详细描述
The influence of the amount of damage and operative interventions on the results of pain treatment in patients with gunshot and mine-explosive wounds at the stages of treatment needs to be studied, because the subjective feelings and emotional experiences experienced by patients during the wounding in combat conditions through the prism of psychological disorders have its features. Since in 82.1% of cases it is not possible to achieve a positive result of treatment, the data of our study will play an important role in their treatment.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Other
入排标准
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •the presence of gunshot wounds
排除标准
- •no gunshot wounds
结局指标
主要结局
The Hospital Anxiety and Depression Scale
时间窗: 12 months
0-7 is the norm 8-13 - mild depressive disorders 14-18 - depressive disorders of medium severity 19-22 - severe depressive disorders 23 and more - depressive disorders of a very severe degree of severity
visual analog scale
时间窗: 12 months
from 0 to 10 points
Didier Bouhassiraa DN4
时间窗: 12 months
4 or more points (a neuropathic pain component is present)
Chaban Quality of Life Scale
时间窗: 12 months
up to 56 inclusive - a very low level 57-66 - low 67-75 - average 76-82 - tall 83-100 is very high
Mississippi PTSD scale (military version)
时间窗: 12 months
the mean values of the total score are 76±18 for well-adjusted servicemen, 86±26 for servicemen with mental disorders, and 130±18 for those with PTSD
次要结局
未报告次要终点
研究者
Vasyl' Horoshko
Chief researcher
Bogomolets National Medical University